Search Results

Costs for CAR T-cell therapies will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.

California Gov. Jerry Brown defied the drug industry Monday by signing a sweeping drug price transparency bill that will force drugmakers to publicly justify big price hikes.

With more than 32 years of experience as an employee benefit specialist, Suzy K. Johnson understands benefits better than most.

The health care growth rate is falling, but employers aren't feeling any relief.

Mark Gaunya and Jennifer Borislow lay out how the government, Big Pharma, hospital systems, and health insurance companies are incentivized to stop price deflation and maintain complexity.

Dr. Keith Smith believes health care pricing in the United States is 'scam' and hes working to change that.

In this interview, Ralph Weber, President and CEO of MediBid, explores his belief that current health care pricing schemes purposefully withhold information from consumers, and why this is going to change.

According to a HealthMine survey of consumers with sponsored health insurance, 39 percent of whom say their plans dont offer them a tool to help them predict how much their care will cost them.